These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8179863)
1. Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs. Hamers FP; Klis SF; Gispen WH; Smoorenburg GF Eur Arch Otorhinolaryngol; 1994; 251(1):23-9. PubMed ID: 8179863 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs. Stengs CH; Klis SF; Huizing EH; Smoorenburg GF Hear Res; 1998 Oct; 124(1-2):108-17. PubMed ID: 9822908 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone. Heijmen PS; Klis SF; De Groot JC; Smoorenburg GF Hear Res; 1999 Feb; 128(1-2):27-39. PubMed ID: 10082280 [TBL] [Abstract][Full Text] [Related]
4. Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity. Wolters FL; de Vocht TF; Klis SF; Hamers FP; Smoorenburg GF Hear Res; 2002 Oct; 172(1-2):110-7. PubMed ID: 12361873 [TBL] [Abstract][Full Text] [Related]
5. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766. Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101 [TBL] [Abstract][Full Text] [Related]
7. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects. O'Leary SJ; Klis SF; de Groot JC; Hamers FP; Smoorenburg GF Hear Res; 2001 Apr; 154(1-2):135-45. PubMed ID: 11423224 [TBL] [Abstract][Full Text] [Related]
11. Reversible cisplatin ototoxicity in the albino guinea pig. Klis SF; O'Leary SJ; Hamers FP; De Groot JC; Smoorenburg GF Neuroreport; 2000 Feb; 11(3):623-6. PubMed ID: 10718325 [TBL] [Abstract][Full Text] [Related]
12. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin. Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of gentamicin on the distribution of cochlear function in albino and pigmented guinea pigs. Conlee JW; Bennett ML; Creel DJ Acta Otolaryngol; 1995 May; 115(3):367-74. PubMed ID: 7653256 [TBL] [Abstract][Full Text] [Related]
14. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs. Konishi T; Gupta BN; Prazma J Am J Otolaryngol; 1983; 4(1):18-26. PubMed ID: 6687035 [TBL] [Abstract][Full Text] [Related]
16. Effect of xipamide and furosemide on guinea pig cochlear recorded potentials. Pose I; Monti JM; Velluti R Braz J Med Biol Res; 1983 Dec; 16(4):317-20. PubMed ID: 6673810 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside. Kong WJ; Ren T; Nuttall AL Hear Res; 1996 Sep; 99(1-2):22-30. PubMed ID: 8970810 [TBL] [Abstract][Full Text] [Related]
18. [Effects of perilymphatic perfusion with cisplatin on the cochlear potential in guinea pigs]. Wu DZ Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):202-4, 254. PubMed ID: 2076322 [TBL] [Abstract][Full Text] [Related]
19. An experimental study of the effects of lead acetate on hearing. Cochlear microphonics and action potential of the guinea pig. Yamamura K; Kishi R; Maehara N; Sadamoto T; Uchino E Toxicol Lett; 1984 Apr; 21(1):41-7. PubMed ID: 6719486 [TBL] [Abstract][Full Text] [Related]
20. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs. Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]